AssetMark Inc
CYTK icon

AssetMark Inc’s Cytokinetics CYTK Stock Holding History

AssetMark Inc’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Buy
3,463
+438
+14% +$27.8K ﹤0.01% 1321
2025
Q4 		$192K Sell
3,025
-338
-10% -$21K ﹤0.01% 1318
2025
Q3 		$185K Buy
3,363
+721
+27% +$29.7K ﹤0.01% 1282
2025
Q2 		$87.3K Buy
2,642
+1,481
+128% +$51.5K ﹤0.01% 1399
2025
Q1 		$46.7K Buy
1,161
+1,151
+11,510% +$52.9K ﹤0.01% 1457
2024
Q4 		$470 Buy
+10
New +$519 ﹤0.01% 2383
2024
Q1 		– Sell
-4
Closed -$334 – 1975
2023
Q4 		$334 Buy
+4
New +$145 ﹤0.01% 1712
2018
Q1 		– Sell
-15
Closed – – 1543
2017
Q4 		$0 Buy
+15
New +$170 ﹤0.01% 1920
2017
Q1 		– Sell
-34
Closed – – 1295
2016
Q4 		$0 Buy
+34
New +$361 ﹤0.01% 1266

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return